Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ, receptors

Journal of Immunology

Volumn 168, Issue 12, 2002, Pages 6375-6381

  Mold, Carolyn ^a   Rodic Polic, Bojana ^a   Du Clos, Terry W ^a  

^a VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COBROTOXIN; COMPLEMENT; FC RECEPTOR; FC RECEPTOR GAMMA 2B; FC RECEPTOR GAMMA 3; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL VIRULENCE; CELL WALL; COMMUNICABLE DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; ENCAPSULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFECTION PREVENTION; INFECTION SENSITIVITY; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

EID: 0037097803     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.12.6375     Document Type: Article

References (46)

1. Divergent roles for Fc receptors and complement in vivo
2. FcRγ chain deletion results in pleiotropic effector cell defects
3. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice
4. Augmented humoral and anaphylactic responses in FcγRII-deficient mice
5. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors
6. Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: A novel murine model for autoimmune glomerular basement membrane disease
7. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses
8. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model
9. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis
10. Community-acquired pneumonia: Etiology, epidemiology and treatment
11. Pathogenesis of pneumococcal infection
12. Emergence of vancomycin tolerance in Streptococcus pneumoniae
13. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae
14. Genetics of a new IgVh (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine
15. C-reactive protein is protective against Streptococcus pneumoniae infection in mice
16. Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse
17. Mouse antibody to phosphorylcholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae
18. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to cell wall and capsular antigens
19. Role of complement in C-reactive protein-mediated protection of mice from Streptococcus pneumoniae
20. Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae
21. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice
22. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice
23. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice
24. Interactions of C-reactive protein with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal polysaccharicle and with the choline phosphatides, lecithin and sphingomyelin
25. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection
26. Blood clearance of Streptococcus pneumoniae by C-reactive protein
27. C-reactive protein binding to murine leukocytes requires Fcγ receptors
28. The major receptor for C-reactive protein on leukocytes is Fcγ,RII
29. Definition of a C-reactive protein binding determinant on histories
30. Affinity labeling of a phosphorylcholine-binding mouse myeloma protein
31. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
32. Regulation of the B cell response to T-dependent antigens by classical pathway complement
33. In vivo polysaccharidepecific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions
34. The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice
35. Serum amyloid P component (SAP) and C-reactive protein (CRP) mediate phagocytosis through murine Fcγ receptors
36. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b
37. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis
38. C-reactive protein binds to FcγRI in transfected COS cells
39. C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele specific
40. The antimicrobial activity of C-reactive protein
41. The effect of C-reactive protein on the complement-mediated stimulation of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6
42. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections
43. Enhanced antigen presentation using human Fcγ receptor (monocyte/macrophage)-specific immunogens
44. IgG-mediated enhancement of antibody responses is low in Fc receptor γ chain-deficient mice and increased in FcγRII-deficient mice
45. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms
46. Molecular and cellular biology of pneumococcal infection